Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Organic & Biomolecular Chemistry
|
October 23, 2010
Oxidative desulfurization-fluorination of thioethers. Application for the synthesis of fluorinated nitrogen containing building blocks
Verena Hugenberg, Roland Fröhlich, Günter Haufe
Bioconjugate Chemistry
|
April 28, 2007
Peptide beacons: a new design for polypeptide-based optical biosensors
Kenneth J Oh, Kevin J Cash, Verena Hugenberg, et al.
The Journal of Organic Chemistry
|
August 27, 2010
Synthesis of geminal difluorides by oxidative desulfurization-difluorination of alkyl aryl thioethers with halonium electrophiles in the presence of fluorinating reagents and its application for 18F-radiolabeling
Verena Hugenberg, Stefan Wagner, Klaus Kopka, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation
Verena Hugenberg, Stefan Wagner, Klaus Kopka, et al.
Nuclear Medicine and Biology
|
April 4, 2025
How green are radiopharmaceutical sciences?
Verena Pichler, Matthias Manfred Herth, Verena Hugenberg, et al.
Bioorganic & Medicinal Chemistry
|
March 13, 2017
Synthesis and evaluation of a [<sup>18</sup>F]BODIPY-labeled caspase-inhibitor
Christian Paul Ortmeyer, Günter Haufe, Katrin Schwegmann, et al.
EJNMMI Radiopharmacy and Chemistry
|
August 14, 2018
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid
Verena Hugenberg, Malte Behrends, Stefan Wagner, et al.
Journal of Medicinal Chemistry
|
August 1, 2013
Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation
Verena Hugenberg, Burkhard Riemann, Sven Hermann, et al.
Journal of Medicinal Chemistry
|
May 1, 2012
A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation
Verena Hugenberg, Hans-Jörg Breyholz, Burkhard Riemann, et al.
Nuclear Medicine and Biology
|
May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability
Verena Hugenberg, Sven Hermann, Fabian Galla, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Organic & Biomolecular Chemistry
|
October 23, 2010
Oxidative desulfurization-fluorination of thioethers. Application for the synthesis of fluorinated nitrogen containing building blocks
Verena Hugenberg, Roland Fröhlich, Günter Haufe
Bioconjugate Chemistry
|
April 28, 2007
Peptide beacons: a new design for polypeptide-based optical biosensors
Kenneth J Oh, Kevin J Cash, Verena Hugenberg, et al.
The Journal of Organic Chemistry
|
August 27, 2010
Synthesis of geminal difluorides by oxidative desulfurization-difluorination of alkyl aryl thioethers with halonium electrophiles in the presence of fluorinating reagents and its application for 18F-radiolabeling
Verena Hugenberg, Stefan Wagner, Klaus Kopka, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation
Verena Hugenberg, Stefan Wagner, Klaus Kopka, et al.
Nuclear Medicine and Biology
|
April 4, 2025
How green are radiopharmaceutical sciences?
Verena Pichler, Matthias Manfred Herth, Verena Hugenberg, et al.
Bioorganic & Medicinal Chemistry
|
March 13, 2017
Synthesis and evaluation of a [<sup>18</sup>F]BODIPY-labeled caspase-inhibitor
Christian Paul Ortmeyer, Günter Haufe, Katrin Schwegmann, et al.
EJNMMI Radiopharmacy and Chemistry
|
August 14, 2018
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid
Verena Hugenberg, Malte Behrends, Stefan Wagner, et al.
Journal of Medicinal Chemistry
|
August 1, 2013
Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation
Verena Hugenberg, Burkhard Riemann, Sven Hermann, et al.
Journal of Medicinal Chemistry
|
May 1, 2012
A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation
Verena Hugenberg, Hans-Jörg Breyholz, Burkhard Riemann, et al.
Nuclear Medicine and Biology
|
May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability
Verena Hugenberg, Sven Hermann, Fabian Galla, et al.
Page
of 2